Paper41988186
Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review.
Fu X and 3 others. Front Immunol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review. Papers, record 41988186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41988186
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerulonephritis, Membranous | Major topic |
| Sjogren's Syndrome | Major topic |
| Rituximab | Major topic |
| Immunologic Factors | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19571279 | M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19571279 | PubMed |
| 2 | 28099084 | Mechanisms and New Strategies for Primary Sjögren's Syndrome. | Annu Rev Med | 2017 | https://conductscience.org/library/papers/28099084 | PubMed |
| 3 | 28610655 | The Diagnosis and Treatment of Sjögren's Syndrome. | Dtsch Arztebl Int | 2017 | https://conductscience.org/library/papers/28610655 | PubMed |
| 4 | 29401359 | Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points. | Nephrol Dial Transplant | 2018 | https://conductscience.org/library/papers/29401359 | PubMed |
| 5 | 23196797 | Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. | Mod Pathol | 2013 | https://conductscience.org/library/papers/23196797 | PubMed |
| 6 | 33367966 | Renal Disease in Primary Sjögren's Syndrome. | Rheumatol Ther | 2021 | https://conductscience.org/library/papers/33367966 | PubMed |
| 7 | 23328976 | IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. | Mod Pathol | 2013 | https://conductscience.org/library/papers/23328976 | PubMed |
| 8 | 19487655 | A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. | Neurology | 2009 | https://conductscience.org/library/papers/19487655 | PubMed |
| 9 | 22146604 | The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. | Mult Scler | 2012 | https://conductscience.org/library/papers/22146604 | PubMed |
| 10 | 25897541 | Efficacy of retreatment with rituximab in patients with primary Sjögren's syndrome. | Clin Exp Rheumatol | 2015 | https://conductscience.org/library/papers/25897541 | PubMed |
| 11 | 31672775 | EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. | Ann Rheum Dis | 2020 | https://conductscience.org/library/papers/31672775 | PubMed |
| 12 | 20131246 | Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20131246 | PubMed |
| 13 | 16253713 | Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sjögren syndrome. | Am J Kidney Dis | 2005 | https://conductscience.org/library/papers/16253713 | PubMed |
| 14 | 11733624 | Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. | Nephrol Dial Transplant | 2001 | https://conductscience.org/library/papers/11733624 | PubMed |
| 15 | 28550082 | Primary Membranous Nephropathy. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28550082 | PubMed |
| 16 | 21527186 | Primary Sjögren's syndrome with minimal change disease--a case report. | Kaohsiung J Med Sci | 2011 | https://conductscience.org/library/papers/21527186 | PubMed |
| 17 | 26092914 | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. | Neurology | 2015 | https://conductscience.org/library/papers/26092914 | PubMed |
| 18 | 25916811 | ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review. | Autoimmun Rev | 2015 | https://conductscience.org/library/papers/25916811 | PubMed |
| 19 | 25760364 | Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25760364 | PubMed |
| 20 | 24566651 | Sjögren syndrome. | CMAJ | 2014 | https://conductscience.org/library/papers/24566651 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41988186
GET https://conductscience.org/api/papers/v1/41988186/references?page=2